跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Conjuvon - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Conjuvon
Approved
STANDARD
Conjuvon
Simcere Pharmaceutical Co., Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
125e53cbf6f0e0b1
Company
Simcere Pharmaceutical Co., Ltd.
Type
Standard
Approval Details
Approval Id
125e53cbf6f0e0b1
Drug Approval Philippines Name
Conjuvon
Product Name
Conjuvon
Registration Number
DR-XY48223
Brand Name
Conjuvon
Generic Name
Edaravone
Dosage Form
Solution for IV Infusion
Dosage Strength
30mg/20mL
Manufacturer
Simcere Pharmaceutical Co., Ltd.
Importer
Conjug 8 Corp.
Distributor
Conjug 8 Corp.
Company Detail Path
/organization/simcere-pharmaceutical-co-ltd
Issuance Date
26 July 2022
Expiry Date
26 July 2027
Pharmacologic Category
Nervous System Drug
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
125e53cbf6f0e0b1
Type
Standard
Back to Philippines FDA Approvals